Novo Nordisk scored a huge legal victory that largely restricts compounding pharmacies from marketing or selling cheaper, unapproved versions of the drugmaker's blockbuster weight loss drug Wegovy and ...
On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug. HealthDay News — Pharmacists may continue making ...
A U.S. district judge on Thursday denied an injunction sought by a compounding industry group to keep making cheaper versions of Novo Nordisk’s (NVO) weight loss drugs Ozempic and Wegovy, even after ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk has notched ...
As more states turn to compounding pharmacies to supply medicines for executions, the leading trade group for compound pharmacists is now discouraging its members from preparing or dispensing drugs ...
Hosted on MSN
Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s Bullish
Novo Nordisk (NVO) announced on Friday that it has secured a legal victory against compounders selling unauthorized versions of the company’s Wegovy and Ozempic drugs. A Texas federal court denied a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results